Almost two weeks ago, the CDC voted to approve a third dose of the Pfizer or Moderna COVID-19 vaccine for immunocompromised Americans, ages 12 and older.
That's nearly 3% of the US population.
Almost two weeks ago, the CDC voted to approve a third dose of the Pfizer or Moderna COVID-19 vaccine for immunocompromised Americans, ages 12 and older.
That's nearly 3% of the US population.